Terms: = Breast cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17 AND Prognosis
6 results:
1. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to myh9.
Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
[TBL] [Abstract] [Full Text] [Related]
2. Pan-cancer genetic analysis of disulfidptosis-related gene set.
Liu H; Tang T
Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
[TBL] [Abstract] [Full Text] [Related]
3. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating myh9-Mediated GSK3β/β-Catenin Signaling.
Li Q; Luo H; Dai FQ; Wang RT; Fan XQ; Luo YY; Deng MS; Wang Y; Long T; Guo W; Xu B; Xu CX; Jin H
Adv Sci (Weinh); 2023 Apr; 10(11):e2203573. PubMed ID: 36757050
[TBL] [Abstract] [Full Text] [Related]
4. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing myh9 and activating the Wnt/beta-catenin pathway.
Li Y; Wang Z; Su P; Liang Y; Li Z; Zhang H; Song X; Han D; Wang X; Liu Y; Yang J; Chen B; Wang L; Zhao W; Yang Q
Mol Ther; 2022 Jan; 30(1):415-430. PubMed ID: 34450253
[TBL] [Abstract] [Full Text] [Related]
5. MicroRNA-214-3p targets the PLAGL2-myh9 axis to suppress tumor proliferation and metastasis in human colorectal cancer.
Zhou Z; Wu L; Liu Z; Zhang X; Han S; Zhao N; Bao H; Yuan W; Chen J; Ji J; Shu X
Aging (Albany NY); 2020 May; 12(10):9633-9657. PubMed ID: 32413870
[TBL] [Abstract] [Full Text] [Related]
6. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
[TBL] [Abstract] [Full Text] [Related]
